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Figure S1. Characterization of mice with Nrf2 gain- and loss-of-function in fibroblasts. Related 
to Figures 1 and 2. 
 (A) Scheme depicting the generation of mice lacking Nrf2 in fibroblasts. (B) Macroscopic 
appearance of ko vs ctrl mice at 10 weeks of age. (C) Flow-cytometric analysis of the immune cell 
composition in back skin from mice during homeostasis at 10 weeks of age. (D) Skin sections from 
PDGFRα-eGFP transgenic mice at P2.5 and 10 weeks of age stained for Ki67, demonstrating a lack 
of proliferating fibroblasts in the skin during homeostasis. (E) – (G) Flow-cytometric analysis of 
(E) whole skin from mice at P2.5 and (F) freshly isolated and cultured primary fibroblasts from 
P2.5 mouse back skin. (G) The percentage of different cell types in whole skin or freshly isolated 
fibroblast cultures. (H) Gene expression of fibroblast and non-fibroblast markers at passage 2 
based on RNA-seq data. (I) Relative expression of Nqo1 by caNrf2 (N=7-22 cultures per genotype 
from different mice) and wild-type fibroblasts treated with tBHQ (N=5), SFN (N=4) or CDDO-Im 
(N=3). (J) Relative expression of Nqo1 in fibroblasts at passage 2 isolated from ko vs ctrl mice 
treated with either vehicle or tBHQ (N=5 cultures per genotype from different mice). (K) ROS 
detection in caNrf2 vs ctrl fibroblasts using the CellROX® Orange ROS detection kit (N=13). (L) 
BrdU incorporation and immunostaining on fibroblasts from ko vs ctrl mice at passage 2 (N=7). 
(M) Gene expression of senescence markers p15ink4b, p16ink4a and p21Cip1 in ko vs ctrl 
fibroblasts at passage 2. Bar graphs shown mean and SEM. ***P<0.001, **P<0.01, *P<0.05, 
Mann-Whitney U test (C, I, M, N) or 2-way ANOVA with Bonferroni posttest (J). Scale bars = 100 




































































































































































































































14d wounds Hoechst Meca32 GFP Overlay
B
Figure S2. Normal wound healing in mice with Nrf2 deficiency in fibroblasts and wound healing 
in young caNrf2-transgenic mice. Related to Figure 4. 
 (A) Examination of wounds from 10 week-old ctrl and caNrf2 mice at 14 days post wounding 
using SA-β-gal histochemistry. (B) Co-immunofluorescence staining of blood vessels in the 
granulation tissue for the endothelial marker Meca32 and GFP (reflecting transgene expression). 
Nuclei were counterstained with Hoechst. (C,D) Examination of wounds from 4 week-old (young) 
ctrl (y-ctrl) and caNrf2 (y-caNrf2) mice at 5 days post wounding using SA-β-gal histochemistry (C) 
or hematoxylin & eosin staining (D). (E) Quantification of reepithelialization and neoepidermal 
thickness in 5-day wounds of ctrl and caNrf2 mice at the age of 4 weeks (N=3 mice, n=6 wounds). 
(F) Expression of Nqo1 in FACS-isolated cells from 5-day wounds of caNrf2 vs ctrl mice (N=3-4 
mice; n=3-4 wounds). *P<0.05, 2-way ANOVA with Bonferroni posttest. (G) Representative 
histological sections of 5-day and 14-day wounds from ko and ctrl mice stained with hematoxylin 
and eosin. Arrow heads point to the edge of the migrating epithelium. (H) Quantification of the 
number of open/closed wounds from ko vs ctrl mice (N=5-7; n=5-7). (I) Morphometric analysis of 
5-day (N=7-8; n=7-8) and (J) 14-day (N=6-9; n=6-9) wounds from ko vs ctrl mice. Bar graphs show 


































































































































































































































































































Figure S3. Related to Figure 4.
caNrf2
ko ctrl ko
Figure S3. Immune cell composition in unwounded skin and 5d wounds. Related to Fig. 4. (A) 
Flow-cytometric analysis of the immune cell composition in unwounded skin from caNrf2 and ctrl 
mice, (B) 5 day wounds from ko and ctrl mice and (C) unwounded skin from ko and ctrl mice. Bar 























































































































Index Name Adjusted p-value Z-score
Combined 
score
1 NFE2L2_20460467_ChIP-Seq_MEFs_Mouse 7.946e-12 -1.89 58.93
2 NRF2_20460467_ChIP-Seq_MEFs_Mouse 7.946e-12 -1.88 58.76
3 Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse 1.126e-11 -1.85 56.54
ChIP-seq Enrichment Analysis 2016 (upregulated ECM proteins and genes)
Index Name Adjusted p-value Z-score
Combined 
score
1 NRF2 pathway Homo sapiens WP2884 2.807e-10 -2.00 53.64
2
XPodNet - protein-protein interactions in 





signaling pathway Mus musculus
WP2841
0.001528 -2.24 21.24














































Figure S4. Related to Figures 5 and 6. 
Gene Symbols: Overlapping ECM proteins and
genes (upregulated)
Abcc1 Cd14 Gja1 Maoa Ptprc Slc6a9
Abcc4 Chl1 Gpc1 Mst1r Ptprs Slc7a11
Abi3bp Chpf2 Gpr176 Myh11 Serpinb5 Sqrdl
Adam23 Cpxm1 Hal Nes Serpinb9b Tfrc
Adcy2 Dysf Heph Nid1 Serpine1 Tgfbr2
Alcam Ecm1 Hspa12a Nqo1 Sfn Ugt1a6b
Aldh3b1 Efnb2 Itga3 Nrcam Siglec1 Ugt1a7c
Angptl2 Epha2 Itga7 Nrp1 Slc1a4 Wnt5a
Atp1b1 Esd Itga8 Palm3 Slc20a2
C3 Ezr Itgam Panx1 Slc22a23
Cat Gclm Itgb2 Pkp3 Slc2a1
Cbr3 Ggt5 Jph2 Ptgr1 Slc6a6
G
Gene Symbols: Overlapping ECM 



















NRF2 protein (Human Protein Atlas)
Normal Skin
Figure S4. Altered expression and deposition of ECM genes in caNrf2 fibroblasts. Related to 
Figures 5 and 6.  
(A) Data from the Human Protein Atlas showing NRF2 (NFE2L2) gene expression in transcripts per 
million from different tissues. (B) Immunohistochemistry images from the Human Protein Atlas 
showing NRF2 expression in normal skin (https://www.proteinatlas.org/ENSG00000116044-
NFE2L2/tissue), basal cell carcinoma and cutaneous squamous cell carcinoma 
(https://www.proteinatlas.org/ENSG00000116044-NFE2L2/pathology/tissue/skin+cancer#ihc). 
Scale bars = 200 μm. (C) Heat maps of differentially expressed genes identified by RNA-seq in 
caNrf2 fibroblasts corresponding to matrisome categories. (D) List of differentially expressed 
genes identified by RNA-seq in caNrf2 fibroblasts corresponding to matrisome categories. (E, F) 
List of genes upregulated (E) or downregulated (F) in caNrf2 fibroblasts that are also upregulated 
or downregulated ECM components according to the mass spectrometry data. (G) ChIP-seq 
enrichment analysis comparing upregulated ECM proteins deposited by caNrf2 fibroblasts to 
previously published ChIP-seq datasets. (H) Comparison of ECM proteins deposited to a larger 
































Genotype (ctrl vs caNrf2) †0.0002









































































































Genotype (ctrl vs caNrf2) 0.4728





Genotype (ctrl vs caNrf2) 0.4728





Genotype (ctrl vs caNrf2) †0.0006





Genotype (ctrl vs caNrf2) †0.0368






















































































































Genotype (ctrl vs caNrf2) 0.9609
Tissue type (0, 5, 14 days) †<0.0001
Factor P-value
Interaction 0.3160
Genotype (ctrl vs caNrf2) 0.2014
Tissue type (0, 5, 14 days) †0.001
Factor P-value
Interaction 0.3684
Genotype (ctrl vs caNrf2) †0.0451
Tissue type (0, 5, 14 days) 0.2841
†
B
Figure S5. Related to Figure 6.
Figure S5. Biochemical analysis of collagen content and cross-linking. Related to Figure 6. (A) 
Collagen analysis and (B) analysis of collagen cross-linking in unwounded skin and in 5 and 14 day 
wounds from caNrf2 vs ctrl mice (N=4-5 mice; n=4-5 wounds, caNrf2 14d N=3; n=3). Bar graphs 






































































































































Figure S6. Nrf2 targets the extracellular matrix to promote fibroblast senescence. Related to 
Figure 7. 
Skin fibroblasts were isolated from wild-type mice and directly plated onto dishes coated with 
ECM deposited by either ctrl or caNrf2 fibroblasts. Cells were plated onto new ECM-coated dishes 
during each passage. (A) Population doublings over 2 passages calculated by counting trypan blue 
excluding cells (N=4-7 ECM-coated dishes from fibroblasts isolated from different mice). (B) BrdU 
incorporation and staining of fibroblasts at passage 2 (N=7). (C) PAI-1 immunohistochemistry 
performed on 5-day wounds and quantification of positive pixels (N=4 mice). (D) PAI-1 
immunohistochemistry performed on sections from unwounded skin of mice at 10 weeks of age. 
(E) qRT-PCR analysis of PAI-1 gene expression in ctrl, caNrf2, ko and wild-type fibroblasts treated 
with tBHQ (N=5-7 cultures per genotype from different mice). Bar graphs show mean and SEM. 
*P<0.05, **P<0.01; 2-way ANOVA with Bonferroni posttest (A) or Mann-Whitney U test (E). Scale 
































































































% Contraction = (5000 – C)/50
% Re-epithelialization = (L+R)/(L+O+R)*100
Neoepidermal thickness= (A1+A2)/(L1+L2)
















% Contraction = (5000 – C)/50
Neoepidermal thickness = A/L




Figure S7. Related to Star Methods. 
Generation of mice with Nrf2 gain- or loss-of-function in fibroblasts and schematic 
representation of the parameters determined in the histomorphometric analysis of wounds. 
(A) Scheme depicting the breeding and control animals used in experiments with caNrf2 
mice/fibroblasts (hemi = hemizygous). (B) Scheme depicting the breeding and control animals 
used in experiments with ko mice/fibroblasts (hemi = hemizygous). (C,D) Scheme depicting a 5 
day (C) and a 14 day (D) wound and the parameters determined in the histomorphometric 
analysis of the wounds.  
 



























Both up/down-regulated genes 
Term ID Description log10 p-value 
GO:0005576 extracellular region -36.0011 
GO:0005615 extracellular space -28.1561 
GO:0070062 extracellular exosome -11.9206 
GO:0005578 proteinaceous extracellular matrix -12.9712 
GO:0031012 extracellular matrix -8.5018 
GO:0009986 cell surface -8.3339 
GO:0016020 membrane -10.4194 
GO:0043235 receptor complex -5.254 
GO:0005887 integral component of plasma membrane -6.7262 
GO:0005829 cytosol -6.4776 
GO:0016021 integral component of membrane -17.5721 
GO:0001527 microfibril -6.0769 
GO:0005604 basement membrane -5.2479 
GO:0005886 plasma membrane -21.5844 
GO:0009897 external side of plasma membrane -5.6706 
Up-regulated genes 
Term ID Description log10 p-value 
GO:0005576 extracellular region -14.5787 
GO:0005829 cytosol -11.094 
GO:0016020 membrane -11.4857 
GO:0045121 membrane raft -4.492 
GO:0070062 extracellular exosome -20.6063 
GO:0005615 extracellular space -18.9521 
GO:0009986 cell surface -9.0261 
GO:0005887 integral component of plasma membrane -4.8389 
GO:0016021 integral component of membrane -11.8602 
GO:0005737 cytoplasm -4.9109 
GO:0043292 contractile fiber -4.0612 
GO:0005886 plasma membrane -21.4293 
GO:0009897 external side of plasma membrane -4.4881 
Down-regulated genes 
Term ID Description log10 p-value 
GO:0005576 extracellular region -17.1548 
GO:0005578 proteinaceous extracellular matrix -9.2326 
GO:0005615 extracellular space -6.4988 
GO:0001527 microfibril -6.1055 
GO:0031012 extracellular matrix -6.2915 
GO:0016021 integral component of membrane -4.8247 
Table S3. Gene Ontology Enrichment Analysis (Cellular Component). Related to Figure 6.  
List of the most significant results obtained from gene ontology enrichment analysis performed 
by EdgeR software. Enriched gene ontology terms listed are those with log10 p-value < -4. 
